Cahill Financial Advisors Inc. Reduces Stake in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE)

Cahill Financial Advisors Inc. trimmed its stake in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) by 1.8% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 20,130 shares of the company’s stock after selling 372 shares during the period. Cahill Financial Advisors Inc. owned approximately 0.20% of iShares U.S. Pharmaceuticals ETF worth $1,421,000 at the end of the most recent quarter.

Several other hedge funds also recently made changes to their positions in the company. Cultivar Capital Inc. purchased a new position in shares of iShares U.S. Pharmaceuticals ETF in the 2nd quarter valued at approximately $25,000. Rothschild Investment LLC purchased a new stake in iShares U.S. Pharmaceuticals ETF in the 2nd quarter valued at approximately $26,000. US Bancorp DE increased its position in iShares U.S. Pharmaceuticals ETF by 137.0% during the 3rd quarter. US Bancorp DE now owns 384 shares of the company’s stock worth $27,000 after purchasing an additional 222 shares during the period. Mather Group LLC. purchased a new stake in shares of iShares U.S. Pharmaceuticals ETF in the second quarter valued at approximately $29,000. Finally, Assetmark Inc. grew its holdings in iShares U.S. Pharmaceuticals ETF by 100.0% during the third quarter. Assetmark Inc. now owns 432 shares of the company’s stock worth $31,000 after acquiring an additional 216 shares during the period.

iShares U.S. Pharmaceuticals ETF Stock Up 0.5 %

NYSEARCA:IHE opened at $68.39 on Friday. iShares U.S. Pharmaceuticals ETF has a fifty-two week low of $57.96 and a fifty-two week high of $72.94. The firm’s fifty day simple moving average is $70.04 and its 200-day simple moving average is $68.73. The stock has a market cap of $690.74 million, a PE ratio of 6.49 and a beta of 0.58.

iShares U.S. Pharmaceuticals ETF Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.